Women's knowledge and experience of atypical pap results in a high risk community

Women and Health

Volumn 36, Issue 4, 2002, Pages 19-29

  McKee, M Diane ^a   Caban, Arlene ^a   Burton, William ^a   Mulvihill, Michael ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

ASCUS cytology; Community health centers; Papanicaloau smear

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; AWARENESS; CANCER RISK; ETHNOLOGY; FEAR; FEMALE; FOLLOW UP; HEALTH SURVEY; HIGH RISK POPULATION; HUMAN; LANGUAGE; LOWEST INCOME GROUP; MEDICAL INFORMATION; PAPANICOLAOU TEST; PATIENT ATTITUDE; PATIENT SATISFACTION; TELEPHONE; URBAN AREA; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY;

EID: 0036987644     PISSN: 03630242     EISSN: None     Source Type: Journal    
DOI: 10.1300/J013v36n04_02     Document Type: Article

References (33)

1. Bennetts, A., Irwig, L., Oldenburg, B., Simpson, J. M., Mock, P., Boyes, A., et al. (1995). PEAPS-Q: a questionnaire to measure the psychosocial effects of having an abnormal pap smear. Journal of Clinical Epidemiology, 48, 1235-43.
2. Beresford, J.S., and Gervaise, P.A. (1986). The emotional impact of abnormal Pap smears on patients referred for colposcopy. Colposcopic Gynecologic Laser Surgery, 2, 83-7.
3. Bosch, F.X. (1999). Trends in cervical cancer mortality. Journal of Epidemiology and Community Health, 53, 392.
4. Brotzman, G., and Apgar, B. (1994). Cervical intraepithelial neoplasia: current management options. Journal of Family Practice, 39, 271-8.
5. Centers for Disease Control and Prevention. (1993). The National Strategic Plan for the early detection and control of breast and cervical cancer. Atlanta, GA: Center for Disease Control and Prevention.
6. Dvorak, K.A., Finnemore, M., and Maksem, J.A. (1999) Histology correlation with atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesion cytology diagnoses: an argument to ensure ASCUS follow-up that is as aggressive as that for LSIL. Diagnostic Cytopathology, 21, 292-5.
7. Frable, W.J. (1999). ASCUS! ASCUS! Down the rabbit hole. Cancer Cytopathology, 87, 319-21.
8. Gilbert, T.J., Sugarman, J.R., and Cobb, N. (1995). Abnormal Pap smears and colposcopic follow-up among American Indian and Alaska native women in the pacific northwest. Journal of American Board of Family Practice, 8, 183-8.
9. Henson, R.M., Wyatt, S.W., and Lee, N.C. (1996). The National Breast and Cervical Cancer Early Detection Project: a comprehensive public health response to two major health issues for women. Journal of Public Health Management and Practice, 2, 36-47.
10. Hubbell, F.A., Chavez, L.R., Mishra, S.I., and Valdez, R.B. (1996). Beliefs about sexual behavior and other predictors of Papanicolaou smear screening among Latinas and Anglo women. Archives Internal Medicine, 156, 2353-8.
11. Kahn, J., Chiou, V., Allen, J., Goodman, E., Perlman, S.E., and Emans, S.J. (1999). Beliefs about Papanicolaou smears and compliance with Papanicolaou smear follow-up in adolescents. Archives of Pediatric Adolescent Medicine, 153, 1046-54.
12. Kavanagh, A., and Broom, D. (1997). Women's understanding of abnormal cervical smear test results: a qualitative interview study. British Medical Journal, 314, 1388.
13. Kurman, R.J., Henson, D.E., Herbst, A.L., Noller, K.L., and Schiffman, M.H. (1994). Interim guidelines for management of abnormal cervical cytology. The 1992 National Cancer Institute Workshop. JAMA, 271, 1866-9.
14. Kurman, R.J., and Solomon, D. (1994). The Bethesda System for Reporting Cervical/Vaginal Cytologic Diagnoses. New York, Springer Verlag.
15. Laedtke, T.W., and Dignan, M. (1992). Compliance with therapy for cervical dysplasia among women of low socioeconomic status. Southern Medical Journal, 85, 5-8.
16. Lauver, D.R., Kruse, K., and Baggot, A., (1999). Women's uncertainties, coping and moods regarding abnormal Papanicolaou results. Journal of Women's Health and Gender-Based Medicine, 8, 1103-12.
17. Lerman, C., Miller, S., Scarborough, Hanjani, P., Nolte, S., and Smith, D. (1991). Adverse psychological consequences of positive cervical cytology. American Journal Obstetrics and Gynecology, 165, 658-62.
18. Lerman, C., Hanjani, P., Caputo, C., Miller, S., Delmoor, E., Nolte, S., and Engstrom, P. (1992). Telephone counseling improves adherence to colposcopy among lower-income minority women. Journal of Clinical Oncology, 10, 330-3.
19. Levanthal, H., Diefenbach, M., and Levanthal, E. (1992). Illness cognition: using common sense to understand treatment adherence and affect cognitive interactions. Cognitive Therapy and Research, 16, 143-63.
20. Levanthal, H., Meyer, D., and Nerenz, D. (1980). The common-sense representation of illness danger. In Rachman, S., (ed.) Medical Psychology, Vol. 2. New York, Pergamon Press.
21. Marcus, A.C., Crane, L.A., Kaplan, C.P., Reading, A.E., Savage, E., Gunning, J., Bernstein, G., and Berek, J.S. (1992). Improving adherence to screening follow-up among women with abnormal pap smears. Medical Care, 30, 216.
22. McKee, M.D., Lurio, J., Marantz, P., Burton, W., and Mulvihill, M. (1999). Barriers to follow-up of abnormal Pap smears in an urban community health center. Archives of Family Medicine, 8, 129-34.
23. McKee, M.D., Schechter, C., Burton, W., and Mulvihill, M. (2001). Predictors of follow-up of atypical and ASCUS Pap smears in a high risk population. Journal of Family Practice, 50 (7), 609.
24. Melnikow, J., Nuovo, J., Willan, A.R., et al. (1998). Natural history of cervical squamous intraepithelial lesions: a meta-analysis. Obstetrics and Gynecology, 92, 727-35.
25. Michielutte, R., Diselker, R.A., Young, L., and May, W.J. (1985). Non-compliance in screening follow-up among family planning clinic patients with cervical dysplasia. Preventive Medicine, 14, 248-57.
26. Miller, A.B., Anderson, G., Brisson, J., Laidlaw, J., LePeitre, N., Makolmson, P., Mirwaldt, P., Stuart, G., and Sullivan, W. (1991). Report of a national workshop on screening for cancer of the cervix. Canadian Medical Association Journal, 145, 1301-25.
27. Nuovo, J., and Melnikow, J. (1995). The management of patients with atypical and low-grade pap smear abnormalities. American Family Physician, 52, 2243-50.
28. Paskett, E.D., White, E., Carter, W., and Chu, J. (1990). Improving follow-up after an abnormal pap smear: a randomized controlled trial. Preventive Medicine, 19, 630.
29. Raab, S.S., Bishop, N.S., and Zaleski, M.S. (1999). Long-term outcome and relative risk in women with atypical squamous cells of undetermined significance. Am Journ Clinical Path, 112, 57-62.
30. Schofield, M.J., Sanson-Fisher, R., Halpin, S., and Redman, S. (1994). Notification and follow-up of Pap test results: current practice and women's preferences. Preventive Medicine, 23, 276-83.
31. Soloman, D., Schiffman, M., and Tarone R. (2001). Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial. Journal of the National Cancer Institute, 93, 293-9.
32. Tomaino-Brunner, C., Freda, M., and Runowicz, C. (1996). "I hope I don't have cancer": colposcopy and minority women. Oncology Nursing Forum, 23, 39-44.
33. Willis, G.B. (1994). Cognitive interviewing and questionnaire design: a training manual. Cognitive Methods Working Papers Series, no. 7, National Center for Health Statistics.